138 related articles for article (PubMed ID: 29966778)
21. Wnt4 is overexpressed in human pituitary adenomas and is associated with tumor invasion.
Li W; Zhang Y; Zhang M; Huang G; Zhang Q
J Clin Neurosci; 2014 Jan; 21(1):137-41. PubMed ID: 24200887
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylated EGFR (pEGFR T693) as a Novel Predictor of Recurrence in Non-Functioning Pituitary Adenomas.
Rai A; Das L; Mukherjee KK; Dhandapani S; Tripathi M; Ahuja CK; Radotra BD; Dutta P
Front Endocrinol (Lausanne); 2021; 12():708111. PubMed ID: 34295309
[TBL] [Abstract][Full Text] [Related]
23. Dysregulation of Wnt pathway components in human salivary gland tumors.
Queimado L; Obeso D; Hatfield MD; Yang Y; Thompson DM; Reis AM
Arch Otolaryngol Head Neck Surg; 2008 Jan; 134(1):94-101. PubMed ID: 18209144
[TBL] [Abstract][Full Text] [Related]
24. Hypermethylation of WIF1 and its inhibitory role in the tumor growth of endometrial adenocarcinoma.
Deng X; Hou C; Wang H; Liang T; Zhu L
Mol Med Rep; 2017 Nov; 16(5):7497-7503. PubMed ID: 28944908
[TBL] [Abstract][Full Text] [Related]
25. Identification of a subtype-specific ENC1 gene related to invasiveness in human pituitary null cell adenoma and oncocytomas.
Feng J; Hong L; Wu Y; Li C; Wan H; Li G; Sun Y; Yu S; Chittiboina P; Montgomery B; Zhuang Z; Zhang Y
J Neurooncol; 2014 Sep; 119(2):307-15. PubMed ID: 24916845
[TBL] [Abstract][Full Text] [Related]
26. Transcriptome Analysis Identifies an Attenuated Local Immune Response in Invasive Nonfunctioning Pituitary Adenomas.
Kim YH; Kim JH
Endocrinol Metab (Seoul); 2019 Sep; 34(3):314-322. PubMed ID: 31565884
[TBL] [Abstract][Full Text] [Related]
27. Elevated Levels of SET and MYND Domain-Containing Protein 3 Are Correlated with Overexpression of Transforming Growth Factor-β1 in Gastric Cancer.
Liu H; Liu Y; Kong F; Xin W; Li X; Liang H; Jia Y
J Am Coll Surg; 2015 Aug; 221(2):579-90. PubMed ID: 26077602
[TBL] [Abstract][Full Text] [Related]
28. Rescued expression of WIF-1 in gallbladder cancer inhibits tumor growth and induces tumor cell apoptosis with altered expression of proteins.
Huang Y; Du Q; Wu W; She F; Chen Y
Mol Med Rep; 2016 Sep; 14(3):2573-81. PubMed ID: 27430608
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of cyclin D1 in human pituitary tumors: relation to MIB-1 and p27/Kip1 labeling indices.
Hewedi IH; Osman WM; El Mahdy MM
J Egypt Natl Canc Inst; 2011 Dec; 23(4):171-9. PubMed ID: 22776845
[TBL] [Abstract][Full Text] [Related]
30. Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53.
Kasuki Jomori de Pinho L; Vieira Neto L; Armondi Wildemberg LE; Gasparetto EL; Marcondes J; de Almeida Nunes B; Takiya CM; Gadelha MR
Neuroendocrinology; 2011; 94(1):39-48. PubMed ID: 21178332
[TBL] [Abstract][Full Text] [Related]
31. MSH6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes.
Uraki S; Ariyasu H; Doi A; Takeshima K; Morita S; Inaba H; Furuta H; Fukuhara N; Inoshita N; Nishioka H; Nakao N; Yamada S; Akamizu T
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325698
[TBL] [Abstract][Full Text] [Related]
32. The expression of ghrelin in somatotroph and other types of pituitary adenomas.
Wasko R; Jaskula M; Kotwicka M; Andrusiewicz M; Jankowska A; Liebert W; Sowinski J
Neuro Endocrinol Lett; 2008 Dec; 29(6):929-38. PubMed ID: 19112387
[TBL] [Abstract][Full Text] [Related]
33. Expression of TGFbeta1 and pituitary adenoma fibrosis.
Wang H; Li W; Shi D; Ye Z; Qin F; Guo Y; Yuan X
Br J Neurosurg; 2009 Jun; 23(3):293-6. PubMed ID: 19533462
[TBL] [Abstract][Full Text] [Related]
34. Membrane-anchored expression of transforming growth factor-alpha in human pituitary adenoma cells.
Ezzat S; Walpola IA; Ramyar L; Smyth HS; Asa SL
J Clin Endocrinol Metab; 1995 Feb; 80(2):534-9. PubMed ID: 7852516
[TBL] [Abstract][Full Text] [Related]
35. Determination of cell proliferation using Mcm2 antigen and evaluation of apoptosis and TGF-beta1 expression in GH-secreting or clinically nonfunctioning pituitary adenomas.
Dallago CM; Barbosa-Coutinho LM; Ferreira NP; Meurer R; Pereira-Lima JF; Oliveira Mda C
Endocr Pathol; 2010 Mar; 21(1):32-9. PubMed ID: 20174894
[TBL] [Abstract][Full Text] [Related]
36. Alterations in CD8
Huang X; Xu J; Wu Y; Sheng L; Li Y; Zha B; Sun T; Yang J; Zang S; Liu J
Pathol Oncol Res; 2021; 27():598887. PubMed ID: 34257554
[TBL] [Abstract][Full Text] [Related]
37. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
Queimado L; Lopes CS; Reis AM
Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
[TBL] [Abstract][Full Text] [Related]
38. Expression and clinical significance of doublecortin (DCX) in pituitary adenoma.
Liu X; Ma L; Wang Z; Ye J; Liu X; Jiang G; Wang H
Bull Cancer; 2019 Dec; 106(12):1080-1085. PubMed ID: 31376915
[TBL] [Abstract][Full Text] [Related]
39. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
40. Regulating effect of MMP-9 and TIMP-1 in pituitary adenoma invasion.
Mao JH; Guo H; Si N; Qiu L; Guo LF; Sun ZS; Xiang Y; Yang XH; Zhao WG; Zhang WC
Genet Mol Res; 2015 Dec; 14(4):17091-8. PubMed ID: 26681056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
